MedTrace Logo

Impact of Geriatrician Interventions on Chemotherapy Delivery in Vulnerable Elderly Oncology Patients

NCT02785887 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 233

Last updated 2019-02-15

No results posted yet for this study

Summary

This is a randomized parallel group trial designed to evaluate the impact of implementing geriatrician-prescribed interventions based on the comprehensive geriatric assessment (CGA), on the ability to deliver adequate chemotherapy treatment, as measured by relative dose intensity (RDI).

Conditions

Interventions

OTHER

Geriatrician review

In addition to routine oncological care, patients will be reviewed by a geriatrician and may receive intervention if CGA deficits are found

Sponsors & Collaborators

  • Azienda USL 4 Prato

    lead OTHER

Principal Investigators

  • Laura Biganzoli, MD · Azienda USL 4 Prato

Study Design

Allocation
RANDOMIZED
Purpose
HEALTH_SERVICES_RESEARCH
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
70 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-08-01
Primary Completion
2018-09-25
Completion
2018-09-25

Countries

  • Italy

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02785887 on ClinicalTrials.gov